2901 Hubbard Road, Suite 2723
Ann Arbor, MI 48109
Available to mentor
Kelvin L. Chou, M.D. is the Alexander S. and Gabriella Karp Professor of Neurology at the University of Michigan. He also serves as Co-Director of the Parkinson’s Disease and Movement Disorders Division and Associate Chair of Faculty Development in Neurology. Dr. Chou has been named to the Best Doctors of America list since 2011 and has clinical expertise and research interests in Parkinson’s disease (PD) and deep brain stimulation (DBS).
Dr. Chou serves as Co-Director of the STIM (Surgical Therapies Improving Movement) Program with a research focus on improving the ability to treat movement disorders patients through DBS. He is also an experienced clinical trialist, conducting numerous clinical trials on new therapies for PD, essential tremor and Huntington disease. He has published over 100 peer-reviewed journal articles, review articles or book chapters on PD and related movement disorders and serves on the editorial board for Neurology and Parkinsonism and Related Disorders.
A strong patient advocate, Dr. Chou serves on the Professional Advisory Board of the Michigan Parkinson Foundation and the Medical Advisory Board of the International Essential Tremor Foundation (IETF). He has also authored a book for patients and families called Deep Brain Stimulation: A New Life for People with Parkinson's, Dystonia and Essential Tremor.
-
MDUniversity of Michigan Medical School, M4101 MSI Box 0624 1301 Catherine, 1998
-
BSUniversity of Michigan, Ann Arbor, 1995
• Deep brain stimulation for Parkinson’s disease, Essential Tremor, and other movement disorders
• Experimental therapeutics for Parkinson’s disease, Essential Tremor and other movement disorders
• Non-motor and motor aspects of Parkinson’s disease
-
2024 Dec 6;Presentation"PPMI Updates: What can these data tell us about disease staging, treatment development now and in the future, and prognosis?"
-
Adams JL, Kangarloo T, Gong Y, Khachadourian V, Tracey B, Volfson D, Latzman RD, Cosman J, Edgerton J, Anderson D, Best A, Kostrzebski MA, Auinger P, Wilmot P, Pohlson Y, Jensen-Roberts S, Müller MLTM, Stephenson D, Dorsey ER, Parkinson Study Group Watch-PD Study Investigators and Collaborators . NPJ Parkinsons Dis, 2024 Jun 12; 10 (1): 112Additional ScholarshipUsing a smartwatch and smartphone to assess early Parkinson's disease in the WATCH-PD study over 12 months.
DOI:10.1038/s41531-024-00721-2 PMID: 38866793 -
Chou K. 2024 Nov 12;Presentation"A Prescription for Better Parkinson's Disease Care"
-
Chou K, Lotia M, Imbus A. 2024 Oct 26;PresentationDBS System Programming Workshop and Advancements in Digital Health
-
Chou K, Lotia M, Imbus A. 2024 Oct 26;PresentationDBS System Programming Workshop and Advancements in Digital Health
-
Bence E, Engelhardt W, Mantena N, Gadzic E, Miocinovic S, Brunner P, Willie J, Heston A, Chen K, Levin E, Chou K, Leventhal D, Opri E. Neuromodulation Technology at the Neural Interface, 2024 Jan 18; 27 (7): s174 - s175.Proceeding / Abstract / PosterID: 317152 Intraoperative Functional Mapping with Deep Brain Stimulation Local Evoked Potentials in Awake and Anesthetized States
DOI:10.1016/j.neurom.2024.06.319 -
Hall V, Chou K, Patil P, Malaga K. Neuromodulation Technology at the Neural Interface, 2024 Jan 18; 27 (7): s231 - s231.Proceeding / Abstract / PosterID: 335187 Optimal Locations for Levodopa and Dyskinesia Reduction in Subthalamic Deep Brain Stimulation for Parkinson Disease
DOI:10.1016/j.neurom.2024.06.411 -
Dam T, Pagano G, Brumm MC, Gochanour C, Poston KL, Weintraub D, Chahine LM, Coffey C, Tanner CM, Kopil CM, Xiao Y, Chowdhury S, Concha-Marambio L, DiBiaso P, Foroud T, Frasier M, Jennings D, Kieburtz K, Merchant K, Mollenhauer B, Montine TJ, Nudelman K, Seibyl J, Sherer T, Singleton A, Stephenson D, Stern M, Soto C, Tolosa E, Siderowf A, Dunn B, Simuni T, Marek K, Parkinson’s Progression Markers Initiative . NPJ Parkinsons Dis, 2024 Sep 27; 10 (1): 178Additional ScholarshipNeuronal alpha-Synuclein Disease integrated staging system performance in PPMI, PASADENA, and SPARK baseline cohorts.
DOI:10.1038/s41531-024-00789-w PMID: 39333167